This site is intended for healthcare professionals
News

NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19.- BMS + Pfizer

Read time: 2 mins
Last updated:13th Sep 2020
Published:13th Sep 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com